Atlas Trials

Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment

Clinical trial NCT07481539 · RECRUITING

Trial details

NCT number
NCT07481539
Sponsor
Azienda Sanitaria Universitaria Friuli Centrale
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bacteria InfectionPiperacillin, Tazobactam Drug Combination
Start date
2026-03-24
Primary completion
2027-04-30
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.